DailyDoctor Archive Specialties Get app
Back to the 12 October 2026 edition

Research · 03 of 06

Preoperative neutrophil-to-lymphocyte ratio and recurrence in high-risk cutaneous squamous cell carcinoma

Note the ratio on pre-excision bloods for high-risk squamous cell carcinoma, but do not alter follow-up intensity on it without validation.

Design
Single-centre retrospective cohort with Fine-Gray and Cox models
Population
420 patients with excised high-risk cutaneous squamous cell carcinoma
Primary outcome
Recurrence-free and overall survival by preoperative neutrophil-to-lymphocyte ratio
Effect
Ratio 3 or more: recurrence-free survival sub-HR 2.43 (95% CI 1.62 to 3.66); overall survival HR 1.49 (1.14 to 1.94)

A single-centre retrospective cohort of 420 patients with high-risk cutaneous squamous cell carcinoma, all excised and with a blood count within 40 days before surgery, tested the neutrophil-to-lymphocyte ratio as a prognostic marker.

The best cut-off was about 3. A ratio of 3 or more was independently associated with recurrence-free survival (sub-hazard ratio 2.43, 95% CI 1.62 to 3.66) and overall survival (hazard ratio 1.49, 1.14 to 1.94), and with other cancer-specific outcomes. Discrimination was modest (AUC 0.622, 0.554 to 0.690).

The authors acknowledge the retrospective single-centre design and possible confounding from unrecorded inflammatory conditions. The cut-off was derived from the same data it was tested in, which tends to overstate performance. The ratio comes from a routine blood count, but it should not drive management by itself.

  • A ratio of 3 or more went with a higher recurrence risk (sub-hazard ratio 2.43).
  • Discrimination was modest (AUC 0.62), so it cannot sort patients alone.
  • The cut-off was chosen in the same cohort, so it needs external validation.
  • Concurrent infection or inflammation can raise the ratio.
  • Use it, if at all, as one of several risk features alongside histology and staging.

Why it matters

It offers a free preoperative signal where most prognostic factors are only known after excision.

Don't overread it

A retrospective, single-centre study with a cut-off derived in the same cohort shows an association, not a validated decision tool.

The statistics, in plain English

An AUC of 0.62 is only a little better than a coin toss (0.5) at separating patients who recur from those who do not. A hazard ratio can be real and still leave the marker poor at predicting for an individual.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

eczemaskincancerhairpsoriasis

Tomorrow morning, before your first patient

One edition a day for dermatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app